Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma

Meric A. Altinoz*, Aysel Ozpinar, Ilhan Elmaci

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)351-369
Number of pages19
JournalNeurosurgical Review
Volume42
Issue number2
DOIs
Publication statusPublished - Jun 2019

Keywords

  • Progesterone receptor
  • Medroxyprogesterone acetate
  • Gliomas
  • CENTRAL-NERVOUS-SYSTEM
  • HORMONE REPLACEMENT THERAPY
  • BREAST-CANCER CELLS
  • MEDROXYPROGESTERONE ACETATE
  • BRAIN-TUMORS
  • ENDOMETRIAL DIFFERENTIATION
  • GLIOBLASTOMA-MULTIFORME
  • MENINGIOMA CELLS
  • RECEPTOR STATUS
  • RISK

Cite this